Use of vasopressors in patients with acute kidney injury on continuous kidney replacement therapy.
<h4>Objective</h4>To investigate whether the use of a specific vasopressor was associated with increased mortality or adverse outcomes in patients with acute kidney injury (AKI) receiving continuous kidney replacement therapy (CKRT).<h4>Methods</h4>Patients with AKI who under...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0315643 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841555455156944896 |
|---|---|
| author | Ambika Ramesh Akshith Doddi Aisha Abbasi Mohammad A Al-Mamun Ankit Sakhuja Khaled Shawwa |
| author_facet | Ambika Ramesh Akshith Doddi Aisha Abbasi Mohammad A Al-Mamun Ankit Sakhuja Khaled Shawwa |
| author_sort | Ambika Ramesh |
| collection | DOAJ |
| description | <h4>Objective</h4>To investigate whether the use of a specific vasopressor was associated with increased mortality or adverse outcomes in patients with acute kidney injury (AKI) receiving continuous kidney replacement therapy (CKRT).<h4>Methods</h4>Patients with AKI who underwent CKRT between 1/1/2012-1/1/2021 at a tertiary academic hospital were included. Cox proportional hazard model was used to assess the relationship between time-dependent vasopressor dose and in-hospital mortality.<h4>Results</h4>There were 641 patients with AKI that required CKRT. In-hospital mortality occurred in 318 (49.6%) patients. Those who died were older (63 vs 57 years), had higher SOFA score (10.6 vs 9) and lactate (6 vs 3.3 mmol/L). In multivariable model, increasing doses of norepinephrine [HR 4.4 (95% CI: 2.3-7, p<0.001)] per 0.02 mcg/min/kg and vasopressin [HR 2.6 (95% CI: 1.9-3.2, p = 0.01)] per 0.02 unit/min during CKRT were associated with in-hospital mortality. The model was adjusted for vasopressor doses and fluid balance, SOFA score, lactate and other markers of severity of illness. Baseline vasopressor doses were not associated with mortality. Most vasopressors were associated with positive daily fluid balance. Among survivors at day 30, mean values of vasopressors were not associated with persistent kidney dysfunction.<h4>Conclusion</h4>The associations between norepinephrine and vasopressin with in-hospital mortality could be related to their common use in this cohort. |
| format | Article |
| id | doaj-art-510c3b208ec746e0bb862d2c6f9b6f5e |
| institution | Kabale University |
| issn | 1932-6203 |
| language | English |
| publishDate | 2024-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-510c3b208ec746e0bb862d2c6f9b6f5e2025-01-08T05:33:01ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-011912e031564310.1371/journal.pone.0315643Use of vasopressors in patients with acute kidney injury on continuous kidney replacement therapy.Ambika RameshAkshith DoddiAisha AbbasiMohammad A Al-MamunAnkit SakhujaKhaled Shawwa<h4>Objective</h4>To investigate whether the use of a specific vasopressor was associated with increased mortality or adverse outcomes in patients with acute kidney injury (AKI) receiving continuous kidney replacement therapy (CKRT).<h4>Methods</h4>Patients with AKI who underwent CKRT between 1/1/2012-1/1/2021 at a tertiary academic hospital were included. Cox proportional hazard model was used to assess the relationship between time-dependent vasopressor dose and in-hospital mortality.<h4>Results</h4>There were 641 patients with AKI that required CKRT. In-hospital mortality occurred in 318 (49.6%) patients. Those who died were older (63 vs 57 years), had higher SOFA score (10.6 vs 9) and lactate (6 vs 3.3 mmol/L). In multivariable model, increasing doses of norepinephrine [HR 4.4 (95% CI: 2.3-7, p<0.001)] per 0.02 mcg/min/kg and vasopressin [HR 2.6 (95% CI: 1.9-3.2, p = 0.01)] per 0.02 unit/min during CKRT were associated with in-hospital mortality. The model was adjusted for vasopressor doses and fluid balance, SOFA score, lactate and other markers of severity of illness. Baseline vasopressor doses were not associated with mortality. Most vasopressors were associated with positive daily fluid balance. Among survivors at day 30, mean values of vasopressors were not associated with persistent kidney dysfunction.<h4>Conclusion</h4>The associations between norepinephrine and vasopressin with in-hospital mortality could be related to their common use in this cohort.https://doi.org/10.1371/journal.pone.0315643 |
| spellingShingle | Ambika Ramesh Akshith Doddi Aisha Abbasi Mohammad A Al-Mamun Ankit Sakhuja Khaled Shawwa Use of vasopressors in patients with acute kidney injury on continuous kidney replacement therapy. PLoS ONE |
| title | Use of vasopressors in patients with acute kidney injury on continuous kidney replacement therapy. |
| title_full | Use of vasopressors in patients with acute kidney injury on continuous kidney replacement therapy. |
| title_fullStr | Use of vasopressors in patients with acute kidney injury on continuous kidney replacement therapy. |
| title_full_unstemmed | Use of vasopressors in patients with acute kidney injury on continuous kidney replacement therapy. |
| title_short | Use of vasopressors in patients with acute kidney injury on continuous kidney replacement therapy. |
| title_sort | use of vasopressors in patients with acute kidney injury on continuous kidney replacement therapy |
| url | https://doi.org/10.1371/journal.pone.0315643 |
| work_keys_str_mv | AT ambikaramesh useofvasopressorsinpatientswithacutekidneyinjuryoncontinuouskidneyreplacementtherapy AT akshithdoddi useofvasopressorsinpatientswithacutekidneyinjuryoncontinuouskidneyreplacementtherapy AT aishaabbasi useofvasopressorsinpatientswithacutekidneyinjuryoncontinuouskidneyreplacementtherapy AT mohammadaalmamun useofvasopressorsinpatientswithacutekidneyinjuryoncontinuouskidneyreplacementtherapy AT ankitsakhuja useofvasopressorsinpatientswithacutekidneyinjuryoncontinuouskidneyreplacementtherapy AT khaledshawwa useofvasopressorsinpatientswithacutekidneyinjuryoncontinuouskidneyreplacementtherapy |